EICHOR
● Completed
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
Condition: Skin Melanoma · Sponsor: R-Pharm
About this study
The goal of this double-blind, randomized study is to establish the equivalence of the efficacy, safety and immunogenicity of the drugs RPH-075 (international nonproprietary name (INN) is pembrolizumab) and Keytruda® (INN is pembrolizumab) when used in patients with unresectable or metastatic skin melanoma first or second line therapy in a monotherapy regimen. The main task is to evaluate and compare the effectiveness of RPH-075 and Keytruda® drugs when used in patients with unresectable or metastatic skin melanoma as a 1 or 2 line therapy in monotherapy regimen, according to the objective response rate (ORR) parameter for up to 24 weeks of therapy.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (36)
| Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of the Russian Federation | Obninsk, Kaluga Oblast, Russia | — |
| State Budgetary Healthcare Institution "Clinical Oncological Dispensary No. 1" of the Ministry of Health of the Krasnodar Territory | Krasnodar, Krasnodar Territory, Russia | — |
| Regional Budgetary Healthcare Institution "Kursk Oncological Research and Clinical Center named after G.E. Ostroverkhov" | Kislino, Kursk Oblast, Russia | — |
| State Budgetary Healthcare Institution of the city of Moscow "Moscow City Oncological Hospital No. 62 of the Department of Health of the City of Moscow" | Istra, Moscow Oblast, Russia | — |
| The State budgetary healthcare Institution of the Stavropol Territory "Pyatigorsk Interdistrict Oncological Dispensary" | Pyatigorsk, Stavropol Territory, Russia | — |
| The State Autonomous Healthcare Institution of the Sverdlovsk region "Sverdlovsk Regional Oncological Dispensary" | Yekaterinburg, Sverdlovsk Oblast, Russia | — |
| State Autonomous Healthcare Institution Republican Clinical Oncological Dispensary of the Ministry of Health of the Republic of Bashkortostan | Ufa, The Republic of Bashkortostan, Russia | — |
| State Autonomous Healthcare Institution "Republican Clinical Oncological Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z.Segal" | Kazan', The Republic of Tatarstan, Russia | — |
| Budgetary Healthcare Institution of the Udmurt Republic "Sergey Grigoryevich Primushko Republican Clinical Oncological Dispensary of the Ministry of Health of the Udmurt Republic" | Izhevsk, Udmurt Republic, Russia | — |
| State Budgetary Healthcare Institution of the Arkhangelsk region "Arkhangelsk Clinical Oncological Dispensary" | Arkhangelsk, Russia | — |
| State Budgetary Healthcare Institution "Regional Oncological Dispensary" | Irkutsk, Russia | — |
| Regional budgetary healthcare institution "Ivanovo Regional Oncological Dispensary" | Ivanovo, Russia | — |
+ 24 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.